Legend Biotech Corporation
LEGN
$18.55
-$0.55-2.88%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.03B | 914.94M | 802.56M | 731.60M | 627.30M |
| Total Other Revenue | 0.00 | -5.92M | -5.66M | -3.24M | 0.00 |
| Total Revenue | 1.03B | 909.02M | 796.90M | 728.36M | 627.30M |
| Cost of Revenue | 822.80M | 776.34M | 698.88M | 665.67M | 648.10M |
| Gross Profit | 206.02M | 132.68M | 98.02M | 62.70M | -20.80M |
| SG&A Expenses | 341.60M | 323.57M | 315.81M | 300.58M | 284.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 1.00M | -- | -- | -- | -- |
| Total Operating Expenses | 1.17B | 1.10B | 1.01B | 966.25M | 932.40M |
| Operating Income | -136.58M | -190.89M | -217.79M | -237.88M | -305.10M |
| Income Before Tax | -282.60M | -222.46M | -304.27M | -197.44M | -158.10M |
| Income Tax Expenses | 14.20M | 17.22M | 21.04M | 20.68M | 18.90M |
| Earnings from Continuing Operations | -296.80 | -239.68 | -325.31 | -218.12 | -177.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -296.80M | -239.68M | -325.31M | -218.12M | -177.00M |
| EBIT | -136.58M | -190.89M | -217.79M | -237.88M | -305.10M |
| EBITDA | -127.18M | -181.43M | -209.13M | -228.45M | -294.40M |
| EPS Basic | -3.22 | -2.60 | -3.54 | -2.38 | -1.94 |
| Normalized Basic EPS | -0.96 | -0.74 | -1.02 | -0.65 | -0.53 |
| EPS Diluted | -3.26 | -2.61 | -3.54 | -2.38 | -1.94 |
| Normalized Diluted EPS | -0.96 | -0.75 | -1.03 | -0.67 | -0.54 |
| Average Basic Shares Outstanding | 737.27M | 735.86M | 734.50M | 732.97M | 731.21M |
| Average Diluted Shares Outstanding | 368.63M | 376.97M | 376.29M | 375.52M | 374.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |